U.S. Home Infusion Therapy Market (2025 - 2033 ) Size, Share & Trends Analysis Report By Type (Product, Services), By Application (Anti-infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition), And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Market Definitions
                        1.2.1. Product Segment
                        1.2.2. Application Segment
                    1.3. Information analysis
                        1.3.1. Market formulation & data visualization
                    1.4. Data validation & publishing
                    1.5. Information Procurement
                        1.5.1. Primary Research
                    1.6. Information or Data Analysis
                    1.7. Market Formulation & Validation
                    1.8. Market Model
                    1.9. Total Market: CAGR Calculation
                    1.10. Objectives
                        1.10.1. Objective 1
                        1.10.2. Objective 2
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Snapshot
                    2.3. Competitive Insights Landscape
Chapter 3. U.S. Home Infusion Therapy Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook.
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Increasing prevalence of chronic diseases and growing geriatric population
                            3.2.1.2. Technological advancements
                            3.2.1.3. Growing incidence of hospital-acquired infections
                        3.2.2. Market restraint analysis
                            3.2.2.1. Presence of complicated reimbursement framework and reimbursement cuts
                    3.3. U.S. Home Infusion Therapy Market Analysis Tools
                        3.3.1. Industry Analysis – Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
                            3.3.2.4. Environmental Landscape
                            3.3.2.5. Legal Landscape
                            3.3.2.6. Social Landscape
Chapter 4. U.S. Home Infusion Therapy Market: Type Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. U.S. Home Infusion Therapy Market Type Movement Analysis
                    4.3. U.S. Home Infusion Therapy Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
                    4.4. Product
                        4.4.1. Market estimates and forecasts 2021 to 2033, (USD Million)
                        4.4.2. Infusion pumps
                            4.4.2.1. Market estimates and forecasts 2021 to 2033, (USD Million)
                            4.4.2.2. Elastomeric
                                4.4.2.2.1. Market estimates and forecasts 2021 to 2033, (USD Million)
                            4.4.2.3. Electromechanical
                                4.4.2.3.1. Market estimates and forecasts 2021 to 2033, (USD Million)
                            4.4.2.4. Gravity
                                4.4.2.4.1. Market estimates and forecasts 2021 to 2033, (USD Million)
                            4.4.2.5. Others
                                4.4.2.5.1. Market estimates and forecasts 2021 to 2033, (USD Million)
                        4.4.3. Intravenous Sets
                            4.4.3.1. Market estimates and forecasts 2021 to 2033, (USD Million)
                        4.4.4. IV Cannulas
                            4.4.4.1. Market estimates and forecasts 2021 to 2033, (USD Million)
                        4.4.5. Needleless Connectors
                            4.4.5.1. Market estimates and forecasts 2021 to 2033, (USD Million)
                    4.5. Services
                        4.5.1. Market estimates and forecasts 2021 to 2033, (USD Million)
Chapter 5. U.S. Home Infusion Therapy Market: Application Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. U.S. Home Infusion Therapy Market Application Movement Analysis
                    5.3. U.S. Home Infusion Therapy Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
                    5.4. Anti-Infective
                        5.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    5.5. Endocrinology
                        5.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                        5.5.2. Diabetes
                            5.5.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                        5.5.3. Others
                            5.5.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    5.6. Hydration Therapy
                        5.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                        5.6.2. Athletes
                            5.6.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                        5.6.3. Others
                            5.6.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    5.7. Chemotherapy
                        5.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    5.8. Enteral Nutrition
                        5.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    5.9. Parenteral Nutrition
                        5.9.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    5.10. Specialty Pharmaceuticals
                        5.10.1. Market estimates and forecasts 2021 to 2033 (USD Million)
                    5.11. Others
                        5.11.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Competitive Landscape
                    6.1. Company/Competition Categorization
                    6.2. Strategy Mapping
                    6.3. Company Market Position Analysis, 2024
                    6.4. Company Profiles/Listing
                        6.4.1. B. Braun Melsungen
                            6.4.1.1. Company overview
                            6.4.1.2. Financial performance
                            6.4.1.3. Product benchmarking
                            6.4.1.4. Strategic initiatives
                        6.4.2. Baxter International
                            6.4.2.1. Company overview
                            6.4.2.2. Financial performance
                            6.4.2.3. Product benchmarking
                            6.4.2.4. Strategic initiatives
                        6.4.3. Caesarea Medical Electronics Ltd.
                            6.4.3.1. Company overview
                            6.4.3.2. Financial performance
                            6.4.3.3. Product benchmarking
                            6.4.3.4. Strategic initiatives
                        6.4.4. CareFusion
                            6.4.4.1. Company overview
                            6.4.4.2. Financial performance
                            6.4.4.3. Product benchmarking
                            6.4.4.4. Strategic initiatives
                        6.4.5. Fresenius Kabi
                            6.4.5.1. Company overview
                            6.4.5.2. Financial performance
                            6.4.5.3. Product benchmarking
                            6.4.5.4. Strategic initiatives
                        6.4.6. ICU Medical
                            6.4.6.1. Company overview
                            6.4.6.2. Financial performance
                            6.4.6.3. Product benchmarking
                            6.4.6.4. Strategic initiatives
                        6.4.7. JMS CO., LTD.
                            6.4.7.1. Company overview
                            6.4.7.2. Financial performance
                            6.4.7.3. Product benchmarking
                            6.4.7.4. Strategic initiatives
                        6.4.8. Smiths Medical, Inc.
                            6.4.8.1. Company overview
                            6.4.8.2. Financial performance
                            6.4.8.3. Product benchmarking
                            6.4.8.4. Strategic initiatives
                        6.4.9. Terumo Corporation
                            6.4.9.1. Company overview
                            6.4.9.2. Financial performance
                            6.4.9.3. Product benchmarking
                            6.4.9.4. Strategic initiatives
                        6.4.10. Coram LLC
                            6.4.10.1. Company overview
                            6.4.10.2. Financial performance
                            6.4.10.3. Product benchmarking
                            6.4.10.4. Strategic initiatives
                        6.4.11. Option Care Enterprises, Inc.
                            6.4.11.1. Company overview
                            6.4.11.2. Financial performance
                            6.4.11.3. Product benchmarking
                            6.4.11.4. Strategic initiatives
                        6.4.12. BioScrip, Inc.
                            6.4.12.1. Company overview
                            6.4.12.2. Financial performance
                            6.4.12.3. Product benchmarking
                            6.4.12.4. Strategic initiatives
                        6.4.13. BriovaRx Infusion Services
                            6.4.13.1. Company overview
                            6.4.13.2. Financial performance
                            6.4.13.3. Product benchmarking
                            6.4.13.4. Strategic initiatives
                        6.4.14. Paragon Healthcare
                            6.4.14.1. Company overview
                            6.4.14.2. Financial performance
                            6.4.14.3. Product benchmarking
                            6.4.14.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. home infusion therapy market, by product, 2021 - 2033 (USD Million)
Table 3 U.S. home infusion therapy market, by application, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Market formulation & validation
Fig. 4 U.S. home infusion therapy market: Market outlook
Fig. 5 U.S. home infusion therapy market: Segment outlook
Fig. 6 U.S. home infusion therapy market: Competitive landscape outlook
Fig. 7 Parent market outlook
Fig. 8 U.S. home infusion therapy market driver impact
Fig. 9 U.S. home infusion therapy market restraint impact
Fig.10  U.S. home infusion therapy market: Type outlook and key takeaways
Fig.11  U.S. home infusion therapy market: Type movement analysis
Fig. 12 Infusion pumps market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 13 Elastomeric market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 14 Electromechanical market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 15 Gravity market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 16 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 17 Intravenous sets market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 18 IV cannulas market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 19 Needleless connectors market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 20 U.S. home infusion therapy market: Application outlook and key takeaways
Fig. 21 U.S. home infusion therapy market: Application movement analysis
Fig. 22 Anti-infective market estimates and forecasts,2021 - 2033 (USD Million)
Fig. 23 Endocrinology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 24 Diabetes market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 25 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 26 Hydration therapy market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 Athletes market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Others market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 29 Chemotherapy market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 30 Enteral nutrition market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 31 Parenteral nutrition market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 32 Specialty pharmaceuticals market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 33 Others market estimates and forecast, 2021 - 2033 (USD Million)